Ketorolac is a good option for relieving pain in patients with sickle cell disease, but there can be a problem with how this agent is prescribed for children.
A 5-year-old boy (20 kg) with sickle cell disease presented with a 2-day history of increasingly severe back pain. A detailed workup showed no signs of infection. The patient’s parents did not want their son to take narcotics for the pain. Thus, the boy was given a prescription for ketorolac -- 10 mg PO every 6 hours x 5 days [0.5 mg/kg dose]).
What’s the problem here?
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.